Live Breaking News & Updates on Manfred Zierhut

Stay updated with breaking news from Manfred zierhut. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Roivant Sciences : NIU Phase 2 Topline Results -April 02, 2024 at 08:48 am EDT

NIU Phase 2 Topline Results and Corporate Updates

April 2024

Forward-Looking Statements

Forward-Looking Statements
. ....

United States , Roivant Priovant , Demyelinating Polyneuropathy Immunovant , Dermatomyositis Priovant , Gravis Immunovant , Exchange Commission , Capital Allocation , Positive Results , Share Repurchase Program Including Purchase , Entire Sumitomo Stake , Reducing Share Count , Next Chapter , Robust Late Stage , Eye Disease , Inflammatory Demyelinating Polyneuropathy , Infectious Uveitis , Treatment Failure , Potential Large Orphan , Unmet Need , Commercial Opportunity , Manfred Zierhut , Vision Loss , Ocular Immunology , Clin Exp Rheum ,